SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-162498
Filing Date
2015-04-30
Accepted
2015-04-30 17:01:20
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d914329d10q.htm 10-Q 294741
2 EX-31.1 d914329dex311.htm EX-31.1 5985
3 EX-31.2 d914329dex312.htm EX-31.2 6029
4 EX-32 d914329dex32.htm EX-32 4078
  Complete submission text file 0001193125-15-162498.txt   3235087

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT itci-20150331.xml EX-101.INS 452156
6 XBRL TAXONOMY EXTENSION SCHEMA itci-20150331.xsd EX-101.SCH 27305
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20150331_cal.xml EX-101.CAL 38504
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20150331_def.xml EX-101.DEF 82021
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20150331_lab.xml EX-101.LAB 249933
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20150331_pre.xml EX-101.PRE 166863
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 15819925
SIC: 2834 Pharmaceutical Preparations